BCL2L1 and acute myeloid leukemia: A recent study described that AML cells showed high baseline expression of phosphorylated Ikaros, CK2 and Bcl-xl, and they further investigated the effect of the CK2 inhibitor CX-4945 on the function of Ikaros in AML [45].